Literature DB >> 9224722

Coupling of Jun amino-terminal kinase and Decapentaplegic signaling pathways in Drosophila morphogenesis.

B Glise1, S Noselli.   

Abstract

Dorsal closure in Drosophila embryos involves the migration of two lateral epithelia toward the dorsal midline to establish the dorsal ectoderm. Previous work showed that this morphogenetic movement depends on the activities of a Jun amino (N)-terminal kinase kinase (JNKK) encoded by the hemipterous (hep) gene, and of a JNK encoded by basket. Hep is required for cell determination in the leading edge of migrating epithelia, by controlling specific expression of the puckered (puc) gene in these cells. During dorsal closure, decapentaplegic (dpp), a member of the transforming growth factor-beta (TGF-beta) superfamily, is expressed in the row of cells making up the leading edge of the epithelia. Here, we show that the small GTPases Dcdc42, Drac1, and the Hep JNKK control dpp expression in this migratory process. Appropriate dpp and puc expression in the leading edge also depends on the inhibitory function of the puc gene. Further, our data suggest that the leading edge is the source of a JNK autocrine signal, and exclude a role of Dpp as such a ligand. Dorsal closure couples JNK and dpp signaling pathways, a situation that may be conserved in vertebrate development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224722     DOI: 10.1101/gad.11.13.1738

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  65 in total

Review 1.  Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton.

Authors:  A Hall; C D Nobes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-07-29       Impact factor: 6.237

Review 2.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

3.  Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling.

Authors:  Yasuhito Hayashi; Chia-Yang Liu; James J Jester; Miyuki Hayashi; I-Jong Wang; James L Funderburgh; Shizuya Saika; Peter J Roughley; Candace Whei-Cheng Kao; Winston Whei-Yang Kao
Journal:  Dev Biol       Date:  2005-01-01       Impact factor: 3.582

4.  Myoblast city, the Drosophila homolog of DOCK180/CED-5, is required in a Rac signaling pathway utilized for multiple developmental processes.

Authors:  K M Nolan; K Barrett; Y Lu; K Q Hu; S Vincent; J Settleman
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

5.  A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.

Authors:  N Tapon; K Nagata; N Lamarche; A Hall
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

Review 6.  TGF-β Family Signaling in Drosophila.

Authors:  Ambuj Upadhyay; Lindsay Moss-Taylor; Myung-Jun Kim; Arpan C Ghosh; Michael B O'Connor
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-09-01       Impact factor: 10.005

7.  Amnioserosa cell constriction but not epidermal actin cable tension autonomously drives dorsal closure.

Authors:  Laurynas Pasakarnis; Erich Frei; Emmanuel Caussinus; Markus Affolter; Damian Brunner
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

8.  Activation of the JNK pathway during dorsal closure in Drosophila requires the mixed lineage kinase, slipper.

Authors:  Beth Stronach; Norbert Perrimon
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

9.  LexA chimeras reveal the function of Drosophila Fos as a context-dependent transcriptional activator.

Authors:  D Szüts; M Bienz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

10.  MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration.

Authors:  Y Xia; C Makris; B Su; E Li; J Yang; G R Nemerow; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.